| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Microbiology (M.J.G.), Urology (M.J.G.), and Pharmacology (W.C.) and New York University Cancer Institute, New York University School of Medicine, New York, New York 10016; and Hospital for Special Surgery, Cornell University School of Medicine (I.R.), New York, New York 10021
Address all correspondence and requests for reprints to: Dr. Michael J. Garabedian, Department of Microbiology, New York University Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, New York 10016. E-mail: garabm01{at}med.nyu.edu.
The Mediator subunits MED14 and MED1 have been implicated in transcriptional regulation by the glucocorticoid receptor (GR) by acting through its activation functions 1 and 2. To understand the contribution of these Mediator subunits to GR gene-specific regulation, we reduced the levels of MED14 and MED1 using small interfering RNAs in U2OS-hGR osteosarcoma cells and examined the mRNA induction by dexamethasone of four primary GR target genes, interferon regulatory factor 8 (IRF8), ladinin 1, IGF-binding protein 1 (IGFBP1), and glucocorticoid-inducible leucine zipper (GILZ). We found that the GR target genes differed in their requirements for MED1 and MED14. GR-dependent mRNA expression of ladinin 1 and IRF8 required both MED1 and MED14, whereas induction of IGFBP1 mRNA by the receptor was dependent upon MED14, but not MED1. In contrast, GILZ induction by GR was largely independent of MED1 and MED14, but required the p160 cofactor transcriptional intermediary factor 2. Interestingly, we observed higher GR occupancy at GILZ than at the IGFBP1 or IRF8 glucocorticoid response element (GREs). In contrast, recruitment of MED14 compared with GR at IGFBP1 and IRF8 was higher than that observed at GILZ. At GILZ, GR and RNA polymerase II were recruited to both the GRE and the promoter, whereas at IGFBP1, RNA polymerase II occupied the promoter, but not the GRE. Thus, MED14 and MED1 are used by GR in a gene-specific manner, and the requirement for the Mediator at GILZ may be bypassed by increased GR and RNA polymerase II occupancy at the GREs. Our findings suggest that modulation of the Mediator subunit activities would provide a mechanism for promoter selectivity by GR.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
E. Ayroldi and C. Riccardi Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action FASEB J, November 1, 2009; 23(11): 3649 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Balamotis, M. A. Pennella, J. L. Stevens, B. Wasylyk, A. S. Belmont, and A. J. Berk Complexity in Transcription Control at the Activation Domain-Mediator Interface Sci. Signal., May 5, 2009; 2(69): ra20 - ra20. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E Ellestad, S. A Malkiewicz, H D. Guthrie, G. R Welch, and T. E Porter Expression and regulation of glucocorticoid-induced leucine zipper in the developing anterior pituitary gland J. Mol. Endocrinol., February 1, 2009; 42(2): 171 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ding, C. Tomomori-Sato, S. Sato, R. C. Conaway, J. W. Conaway, and T. G. Boyer MED19 and MED26 Are Synergistic Functional Targets of the RE1 Silencing Transcription Factor in Epigenetic Silencing of Neuronal Gene Expression J. Biol. Chem., January 30, 2009; 284(5): 2648 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, T. Dang, R. D. Blind, Z. Wang, C. N. Cavasotto, A. B. Hittelman, I. Rogatsky, S. K. Logan, and M. J. Garabedian Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression Mol. Endocrinol., August 1, 2008; 22(8): 1754 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jeanneteau, M. J. Garabedian, and M. V. Chao Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect PNAS, March 25, 2008; 105(12): 4862 - 4867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ge, Y.-W. Cho, H. Guo, T. B. Hong, M. Guermah, M. Ito, H. Yu, M. Kalkum, and R. G. Roeder Alternative Mechanisms by Which Mediator Subunit MED1/TRAP220 Regulates Peroxisome Proliferator-Activated Receptor {gamma}-Stimulated Adipogenesis and Target Gene Expression Mol. Cell. Biol., February 1, 2008; 28(3): 1081 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aoyagi and T. K. Archer Nicotinamide Uncouples Hormone-Dependent Chromatin Remodeling from Transcription Complex Assembly Mol. Cell. Biol., January 1, 2008; 28(1): 30 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Mathew, S. Sengupta, A. Kawakami, E. A. Andreasen, C. V. Lohr, C. A. Loynes, S. A. Renshaw, R. T. Peterson, and R. L. Tanguay Unraveling Tissue Regeneration Pathways Using Chemical Genetics J. Biol. Chem., November 30, 2007; 282(48): 35202 - 35210. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen and R. G. Roeder The Mediator subunit MED1/TRAP220 is required for optimal glucocorticoid receptor-mediated transcription activation Nucleic Acids Res., September 25, 2007; 35(18): 6161 - 6169. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hebbar and T. K. Archer Chromatin-dependent Cooperativity between Site-specific Transcription Factors in Vivo J. Biol. Chem., March 16, 2007; 282(11): 8284 - 8291. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, W. Chen, E. Kono, T. Dang, and M. J. Garabedian Modulation of Glucocorticoid Receptor Phosphorylation and Transcriptional Activity by a C-Terminal-Associated Protein Phosphatase Mol. Endocrinol., March 1, 2007; 21(3): 625 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He and S. S. Simons Jr. STAMP, a Novel Predicted Factor Assisting TIF2 Actions in Glucocorticoid Receptor-Mediated Induction and Repression Mol. Cell. Biol., February 15, 2007; 27(4): 1467 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. M. C. Koeijvoets, E. F. C. van Rossum, G. M. Dallinga-Thie, E. W. Steyerberg, J. C. Defesche, J. J. P. Kastelein, S. W. J. Lamberts, and E. J. G. Sijbrands A Functional Polymorphism in the Glucocorticoid Receptor Gene and Its Relation to Cardiovascular Disease Risk in Familial Hypercholesterolemia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4131 - 4136. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |